Mini Review
Published on 26 Jul 2023
C-reactive protein: a target for therapy to reduce inflammation
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1237729
- 14,176 views
- 74 citations
Type at least 3 characters
2,804 articles
Original Research
Published on 26 Jul 2023
RSV replication modifies the XBP1s binding complex on the IRF1 upstream enhancer to potentiate the mucosal anti-viral response
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1197356
- 4,588 views
- 3 citations
Editorial
Published on 26 Jul 2023
Editorial: Non-canonical NF-κB signaling in immune-mediated inflammatory diseases and malignancies
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1252939
- 3,389 views
- 5 citations
Review
Published on 25 Jul 2023
Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1214289
- 7,244 views
- 20 citations
Original Research
Published on 21 Jul 2023
Rai14 is a novel interactor of Invariant chain that regulates macropinocytosis
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1182180
- 3,302 views
- 1 citation
Original Research
Published on 20 Jul 2023
EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1191866
- 4,902 views
- 5 citations
Review
Published on 20 Jul 2023
Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1232629
- 7,800 views
- 15 citations
Original Research
Published on 20 Jul 2023
Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1135373
- 7,798 views
- 8 citations
Review
Published on 20 Jul 2023
Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1219487
- 5,339 views
- 12 citations
Original Research
Published on 20 Jul 2023
A novel 3D spheroid model of rheumatoid arthritis synovial tissue incorporating fibroblasts, endothelial cells, and macrophages
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1188835
- 7,059 views
- 10 citations
Original Research
Published on 20 Jul 2023
Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1197650
- 4,537 views
- 3 citations
Review
Published on 18 Jul 2023
NF-kB’s contribution to B cell fate decisions
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1214095
- 18,441 views
- 39 citations
Original Research
Published on 18 Jul 2023
MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1193179
- 8,467 views
- 4 citations
Correction
Published on 18 Jul 2023
Corrigendum: IL-3 produced by T cells is crucial for basophil extravasation in hapten- induced allergic contact dermatitis
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1254157
- 1,389 views
Correction
Published on 18 Jul 2023
Corrigendum: The critical role of PARPs in regulating innate immune responses
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1253094
- 1,418 views
- 2 citations
Editorial
Published on 17 Jul 2023
Editorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1251577
- 3,384 views